Munes Albadaineh
Researcher
Also affiliated: King Abdullah Medical City (2013–2014)
Unknown Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Munes Albadaineh's research focuses on clinical cardiology and cardiovascular outcomes. Recent publications investigate the safety and efficacy of enoxaparin in percutaneous coronary intervention, the prevalence of QRS fragmentation during the COVID-19 pandemic, and the relationship between left ventricular apical long-axis length and ejection fraction. Other work examines heart failure with preserved ejection fraction recognition, and hypertensive response during dobutamine stress echocardiography. Albadaineh also contributes to discussions on the challenges within interventional cardiology fellowship programs and the real-world cardiovascular outcomes of combined SGLT2 inhibitor and GLP1 receptor agonist therapy in type 2 diabetes. Collaborations include work with Malek Alaiwah and Omar Alqaisi, both at the University of Arkansas for Medical Sciences.
Metrics
- h-index: 4
- Publications: 6
- Citations: 89
Selected Publications
-
The Growing Concern of Unfilled Interventional Cardiology Fellowships: Causes, Trends, and the Path Forward (2026)
-
26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS (2026)
-
Prevalence and Most Commonly Encountered QRS Fragmentation Morphology and Early Repolarization ST-Segment Changes During the Height of the COVID-19 Pandemic: A Single-Center Experience (2026)
-
Left Ventricular Apical Long-Axis Length and Ejection Fraction: A Proof-of-Concept Analysis (2025)
-
Improving Recognition of Heart Failure With Preserved Ejection Fraction in the Outpatient Setting: A Pilot Study of Readily Useful Clinical Attributes (2025)
-
HYPERTENSIVE RESPONSE DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY AND RISK OF NEW ONSET HEART FAILURE (2025)
-
SIGNIFICANCE OF ISCHEMIC ELECTROCARDIOGRAM CHANGES IN THE SETTING OF NORMAL IMAGING IN DOBUTAMINE STRESS ECHOCARDIOGRAPHY (2025)
-
Percutaneous pericardiocentesis using the apical approach: case series and review of the literature (2024)
-
Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention (2024)
-
Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention (2024)
-
100.51 Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention (2024)
Collaboration Network
Top Collaborators
- Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention
- Percutaneous pericardiocentesis using the apical approach: case series and review of the literature
- 100.51 Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- SIGNIFICANCE OF ISCHEMIC ELECTROCARDIOGRAM CHANGES IN THE SETTING OF NORMAL IMAGING IN DOBUTAMINE STRESS ECHOCARDIOGRAPHY
Showing 5 of 6 shared publications
- Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention
- 100.51 Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- SIGNIFICANCE OF ISCHEMIC ELECTROCARDIOGRAM CHANGES IN THE SETTING OF NORMAL IMAGING IN DOBUTAMINE STRESS ECHOCARDIOGRAPHY
- HYPERTENSIVE RESPONSE DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY AND RISK OF NEW ONSET HEART FAILURE
- Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention
- Percutaneous pericardiocentesis using the apical approach: case series and review of the literature
- 100.51 Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Percutaneous pericardiocentesis using the apical approach: case series and review of the literature
- SIGNIFICANCE OF ISCHEMIC ELECTROCARDIOGRAM CHANGES IN THE SETTING OF NORMAL IMAGING IN DOBUTAMINE STRESS ECHOCARDIOGRAPHY
- HYPERTENSIVE RESPONSE DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY AND RISK OF NEW ONSET HEART FAILURE
- Left Ventricular Apical Long-Axis Length and Ejection Fraction: A Proof-of-Concept Analysis
- SIGNIFICANCE OF ISCHEMIC ELECTROCARDIOGRAM CHANGES IN THE SETTING OF NORMAL IMAGING IN DOBUTAMINE STRESS ECHOCARDIOGRAPHY
- HYPERTENSIVE RESPONSE DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY AND RISK OF NEW ONSET HEART FAILURE
- Prevalence and Most Commonly Encountered QRS Fragmentation Morphology and Early Repolarization ST-Segment Changes During the Height of the COVID-19 Pandemic: A Single-Center Experience
- 26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS
- SIGNIFICANCE OF ISCHEMIC ELECTROCARDIOGRAM CHANGES IN THE SETTING OF NORMAL IMAGING IN DOBUTAMINE STRESS ECHOCARDIOGRAPHY
- HYPERTENSIVE RESPONSE DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY AND RISK OF NEW ONSET HEART FAILURE
- Left Ventricular Apical Long-Axis Length and Ejection Fraction: A Proof-of-Concept Analysis
- 26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS
- Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention
- 100.51 Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention
- 100.51 Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention
- 100.51 Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention
- 100.51 Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- SIGNIFICANCE OF ISCHEMIC ELECTROCARDIOGRAM CHANGES IN THE SETTING OF NORMAL IMAGING IN DOBUTAMINE STRESS ECHOCARDIOGRAPHY
- HYPERTENSIVE RESPONSE DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY AND RISK OF NEW ONSET HEART FAILURE
- 26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS
- Improving Recognition of Heart Failure With Preserved Ejection Fraction in the Outpatient Setting: A Pilot Study of Readily Useful Clinical Attributes
- Left Ventricular Apical Long-Axis Length and Ejection Fraction: A Proof-of-Concept Analysis
- 26-A-11242-ACC REAL-WORLD CARDIOVASCULAR OUTCOMES OF COMBINED SGLT2 INHIBITOR AND GLP1 RECEPTOR AGONIST THERAPY IN TYPE 2 DIABETES INDIVIDUALS
- 100.51 Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- Safety and Efficacy of Enoxaparin During Percutaneous Coronary Intervention
- SIGNIFICANCE OF ISCHEMIC ELECTROCARDIOGRAM CHANGES IN THE SETTING OF NORMAL IMAGING IN DOBUTAMINE STRESS ECHOCARDIOGRAPHY
- HYPERTENSIVE RESPONSE DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY AND RISK OF NEW ONSET HEART FAILURE
- SIGNIFICANCE OF ISCHEMIC ELECTROCARDIOGRAM CHANGES IN THE SETTING OF NORMAL IMAGING IN DOBUTAMINE STRESS ECHOCARDIOGRAPHY
- HYPERTENSIVE RESPONSE DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY AND RISK OF NEW ONSET HEART FAILURE
Similar Researchers
Based on overlapping research topics